MSB 3.33% $1.40 mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-532

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,294 Posts.
    lightbulb Created with Sketch. 564
    Inconvenient question!!

    probably all here agree in around 12 months we have vaccine.
    Oxford Uni suggest early September if all goes ok but kets assume 3/2021 we start

    yes of course still will hav

    e many cases around the world but the pick of season isvwhat web have today all way 3/2021

    but becausevwe have zero capabilities to produce volume and assume from day 1 we receive ok and order we will need some time to vamp products, im under the opinion we will be between hell and heaven with very little or no teal income at all (aside of the one forecast initially for remestell .or maybe a little bit but far from huge millions of clients like suggested here.

    maybe we pick st 2.81 this Friday and will retrace to 2.50/2.60 much earlier than achieve 3 ( probably just and as soon final aprove will come)

    welcome opinions

    cato

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.40
Change
0.045(3.33%)
Mkt cap ! $1.592B
Open High Low Value Volume
$1.35 $1.42 $1.33 $3.802M 2.753M

Buyers (Bids)

No. Vol. Price($)
2 23940 $1.39
 

Sellers (Offers)

Price($) Vol. No.
$1.40 22571 2
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.